The immunomodulatory oligodendrocyte

Brain Research

Volumn 1641, Issue , 2016, Pages 139-148

  Zeis, Thomas ^a   Enz, Lukas ^a   Schaeren Wiemers, Nicole ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Chemokine; Cytokine; Immune process; Immunomodulation; Inflammation; Multiple Sclerosis; NIRegs; Oligodendrocyte; Tetraspanins

Indexed keywords

CD200 ANTIGEN; CD47 ANTIGEN; CD59 ANTIGEN; CD81 ANTIGEN; CD9 ANTIGEN; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; DECAY ACCELERATING FACTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE COFACTOR PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SCLEROPROTEIN; TETRASPANIN;

ANTIGEN PRESENTATION; CYTOKINE PRODUCTION; GENE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANIMAL; BRAIN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; HUMANS; NEUROIMMUNOMODULATION; OLIGODENDROGLIA;

EID: 84979496998     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.09.021     Document Type: Review

References (93)

1. Ashbaugh, J.J., et al. IL7Ralpha contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages. J. Immunol. 190 (2013), 4525–4534.
2. Baggiolini, M., Clark-Lewis, I., Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 307 (1992), 97–101.
3. Balabanov, R., et al. Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis. J. Neurosci. 27 (2007), 2013–2024.
4. Barnett, M.H., Prineas, J.W., Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55 (2004), 458–468.
5. Bergsteindottir, K., et al. In the presence of dexamethasone, gamma interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 89 (1992), 9054–9058.
6. Bhat, N.R., Zhang, P., Activation of mitogen-activated protein kinases in oligodendrocytes. J. Neurochem. 66 (1996), 1986–1994.
7. Birling, M.C., et al. A novel rat tetraspan protein in cells of the oligodendrocyte lineage. J. Neurochem. 73 (1999), 2600–2608.
8. Bradl, M., Lassmann, H., Oligodendrocytes: biology and pathology. Acta Neuropathol. 119 (2010), 37–53.
9. Brinkmann, B.G., et al. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 59 (2008), 581–595.
10. Cahoy, J.D., et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28 (2008), 264–278.
11. Cannella, B., Raine, C.S., Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann. Neurol. 55 (2004), 46–57.
12. Cheepsunthorn, P., Palmer, C., Connor, J.R., Cellular distribution of ferritin subunits in postnatal rat brain. J. Comp. Neurol. 400 (1998), 73–86.
13. Chitnis, T., et al. Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration. Am. J. Pathol. 170 (2007), 1695–1712.
14. Choi, C., Benveniste, E.N., Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res. Brain Res. Rev. 44 (2004), 65–81.
15. Connor, J.R., Menzies, S.L., Relationship of iron to oligodendrocytes and myelination. Glia 17 (1996), 83–93.
16. Dell'Albani, P., et al. Oligodendroglial survival factors, PDGF-AA and CNTF, activate similar JAK/STAT signaling pathways. J. Neurosci. Res. 54 (1998), 191–205.
17. Deshmane, S.L., et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interfer. Cytokine Res. 29 (2009), 313–326.
18. Dewar, D., Underhill, S.M., Goldberg, M.P., Oligodendrocytes and ischemic brain injury. J. Cereb. Blood Flow Metab. 23 (2003), 263–274.
19. Dowling, P., et al. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184 (1996), 1513–1518.
20. Dunkelberger, J.R., Song, W.C., Complement and its role in innate and adaptive immune responses. Cell Res. 20 (2010), 34–50.
21. Engering, A., Pieters, J., Association of distinct tetraspanins with MHC class II molecules at different subcellular locations in human immature dendritic cells. Int. Immunol. 13 (2001), 127–134.
22. Farber, J.M., Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61 (1997), 246–257.
23. Gaffen, S.L., et al. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14 (2014), 585–600.
24. Gasque, P., Morgan, B.P., Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes. Immunology 89 (1996), 338–347.
25. Gitik, M., et al. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPalpha (signal regulatory protein-alpha) on phagocytes. J. Neuroinflamm., 8, 2011, 24.
26. Green, D.R., Ferguson, T.A., The role of Fas ligand in immune privilege. Nat. Rev. Mol. Cell Biol. 2 (2001), 917–924.
27. Greenwald, R.J., Freeman, G.J., Sharpe, A.H., The B7 family revisited. Annu. Rev. Immunol. 23 (2005), 515–548.
28. Griffiths, M.R., Gasque, P., Neal, J.W., The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review. Int. J. Inflamm., 2010, 2010, 151097.
29. Gu, L., et al. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404 (2000), 407–411.
30. Gu, W.L., et al. Expression and regulation of versican in neural precursor cells and their lineages. Acta Pharmacol. Sin. 28 (2007), 1519–1530.
31. Hammond, C., et al. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. J. Immunol. 161 (1998), 3282–3291.
32. Hinojosa, A.E., et al. CCL2/MCP-1 modulation of microglial activation and proliferation. J. Neuroinflamm., 8, 2011, 77.
33. Hirayama, M., et al. Induction of human leukocyte antigen-A,B,C and -DR on cultured human oligodendrocytes and astrocytes by human gamma-interferon. Neurosci. Lett. 72 (1986), 369–374.
34. Hoftberger, R., et al. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 14 (2004), 43–50.
35. Horiuchi, M., et al. Cooperative contributions of interferon regulatory factor 1 (IRF1) and IRF8 to interferon-gamma-mediated cytotoxic effects on oligodendroglial progenitor cells. J. Neuroinflamm., 8, 2011, 8.
36. Hosokawa, M., et al. Expression of complement messenger RNAs and proteins by human oligodendroglial cells. Glia 42 (2003), 417–423.
37. International Multiple Sclerosis Genetics Consortium, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476 (2011), 214–219.
38. Isailovic, N., et al. Interleukin-17 and innate immunity in infections and chronic inflammation. J. Autoimmun. 60 (2015), 1–11.
39. Ishibashi, T., et al. Tetraspanin protein CD9 is a novel paranodal component regulating paranodal junctional formation. J. Neurosci. 24 (2004), 96–102.
40. Jones, E.L., Demaria, M.C., Wright, M.D., Tetraspanins in cellular immunity. Biochem. Soc. Trans. 39 (2011), 506–511.
41. Kemper, C., Atkinson, J.P., T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 7 (2007), 9–18.
42. Kim, S., et al. Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors. J. Neurochem. 116 (2011), 53–66.
43. Koning, N., et al. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron–glia and glia–glia interactions. J. Neuropathol. Exp. Neurol. 68 (2009), 159–167.
44. Koning, N., et al. Restoring immune suppression in the multiple sclerosis brain. Prog. Neurobiol. 89 (2009), 359–368.
45. Kumar, S., et al. NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo. J. Neurosci Res. 54 (1998), 754–765.
46. Kummer, J.A., et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J. Histochem. Cytochem. 55 (2007), 443–452.
47. Lee, E.Y., Lee, Z.H., Song, Y.W., CXCL10 and autoimmune diseases. Autoimmun. Rev. 8 (2009), 379–383.
48. Li, G.L., Farooque, M., Olsson, Y., Changes of Fas and Fas ligand immunoreactivity after compression trauma to rat spinal cord. Acta Neuropathol. 100 (2000), 75–81.
49. Liu, J., et al. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J. Exp. Med. 201 (2005), 567–577.
50. Longhi, M.P., et al. Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner. J. Immunol. 175 (2005), 7098–7102.
51. Longhi, M.P., et al. Holding T cells in check–a new role for complement regulators?. Trends Immunol. 27 (2006), 102–108.
52. Longhi, M.P., et al. CD59a deficiency exacerbates influenza-induced lung inflammation through complement-dependent and -independent mechanisms. Eur. J. Immunol. 37 (2007), 1266–1274.
53. Lucchinetti, C., et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47 (2000), 707–717.
54. Majed, H.H., et al. A novel role for Sema3A in neuroprotection from injury mediated by activated microglia. J. Neurosci. 26 (2006), 1730–1738.
55. Marques, R.E., et al. Targeting CCL5 in inflammation. Expert Opin. Ther. Targets 17 (2013), 1439–1460.
56. Martinvalet, D., Zhu, P., Lieberman, J., Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis. Immunity 22 (2005), 355–370.
57. McTigue, D.M., Tripathi, R.B., The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 107 (2008), 1–19.
58. Mela, A., Goldman, J.E., The tetraspanin KAI1/CD82 is expressed by late-lineage oligodendrocyte precursors and may function to restrict precursor migration and promote oligodendrocyte differentiation and myelination. J. Neurosci. 29 (2009), 11172–11181.
59. Mela, A., Goldman, J.E., CD82 blocks cMet activation and overcomes hepatocyte growth factor effects on oligodendrocyte precursor differentiation. J. Neurosci. 33 (2013), 7952–7960.
60. Menten, P., Wuyts, A., Van Damme, J., Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 13 (2002), 455–481.
61. Merabova, N., et al. JCV agnoprotein-induced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons. J. Cell. Physiol. 227 (2012), 3119–3127.
62. Mirsky, R., et al. Myelin-specific proteins and glycolipids in rat Schwann cells and oligodendrocytes in culture. J. Cell Biol. 84 (1980), 483–494.
63. de Monasterio-Schrader, P., et al. Uncoupling of neuroinflammation from axonal degeneration in mice lacking the myelin protein tetraspanin-2. Glia 61 (2013), 1832–1847.
64. Moyon, S., et al. Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration. J. Neurosci. 35 (2015), 4–20.
65. Nakanishi, K., et al. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 12 (2001), 53–72.
66. Nave, K.A., Trapp, B.D., Axon-glial signaling and the glial support of axon function. Annu. Rev. Neurosci. 31 (2008), 535–561.
67. Okamura, R.M., et al. Immunological properties of human embryonic stem cell-derived oligodendrocyte progenitor cells. J. Neuroimmunol. 192 (2007), 134–144.
68. Ott, M., et al. Mitochondria, oxidative stress and cell death. Apoptosis 12 (2007), 913–922.
69. Peferoen, L., et al. Oligodendrocyte-microglia cross-talk in the central nervous system. Immunology 141 (2014), 302–313.
70. Prieto, A.L., Weber, J.L., Lai, C., Expression of the receptor protein-tyrosine kinases Tyro-3, Axl, and mer in the developing rat central nervous system. J. Comp. Neurol. 425 (2000), 295–314.
71. Ramesh, G., et al. A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi. J. Neuroinflamm., 9, 2012, 72.
72. Rubinstein, E., et al. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur. J. Immunol. 26 (1996), 2657–2665.
73. Sarma, J.V., Ward, P.A., The complement system. Cell Tissue Res. 343 (2011), 227–235.
74. Scheller, J., et al. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 1813 (2011), 878–888.
75. Schroder, K., Tschopp, J., The inflammasomes. Cell 140 (2010), 821–832.
76. Scolding, N.J., Morgan, B.P., Compston, D.A., The expression of complement regulatory proteins by adult human oligodendrocytes. J. Neuroimmunol. 84 (1998), 69–75.
77. Shen, F., et al. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J. Leukoc. Biol. 77 (2005), 388–399.
78. Steinman, L., Connections between the immune system and the nervous system. Proc. Natl. Acad. Sci. USA 90 (1993), 7912–7914.
79. Stolt, C.C., et al. Transcription factors Sox8 and Sox10 perform non-equivalent roles during oligodendrocyte development despite functional redundancy. Development 131 (2004), 2349–2358.
80. Sullivan, C.D., Geisert, E.E. Jr., Expression of rat target of the antiproliferative antibody (TAPA) in the developing brain. J. Comp. Neurol. 396 (1998), 366–380.
81. Szollosi, J., et al. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J. Immunol. 157 (1996), 2939–2946.
82. Thorburne, S.K., Juurlink, B.H., Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J. Neurochem. 67 (1996), 1014–1022.
83. Trapp, B.D., Pathogenesis of multiple sclerosis: the eyes only see what the mind is prepared to comprehend. Ann. Neurol. 55 (2004), 455–457.
84. Tzartos, J.S., et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172 (2008), 146–155.
85. Uberti, D., et al. Hydrogen peroxide induces nuclear translocation of p53 and apoptosis in cells of oligodendroglia origin. Brain Res. Mol. Brain Res. 65 (1999), 167–175.
86. Walz, A., et al. Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J. Leukoc. Biol. 62 (1997), 604–611.
87. Wang, S., Chen, L., Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses. Microbes Infect. 6 (2004), 759–766.
88. Wight, T.N., Kang, I., Merrilees, M.J., Versican and the control of inflammation. Matrix Biol. 35 (2014), 152–161.
89. Williams, A., et al. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?. Brain 130 (2007), 2554–2565.
90. Zeis, T., et al. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 131 (2008), 288–303.
91. Zeis, T., Schaeren-Wiemers, N., Lame ducks or fierce creatures?-the role of oligodendrocytes in multiple sclerosis. J. Mol. Neurosci. 35 (2008), 91–100.
92. Zeis, T., et al. Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling. Brain Behav. Immun. 48 (2015), 313–325.
93. Zhang, Y., et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34 (2014), 11929–11947.